Table 1.

Baseline characteristics of the subjects studied

Subject	Gender	Age (years)	Height (cm)	Weight (kg)	FEV1 (l)	FEV1 (% predicted)	Usual inhaled corticosteroid
1	M	55	192	78	3.8	91	Beclometasone diproprionate
2	M	50	173	78	2.8	80	None
3	F	50	160	86	2.55	103	Beclometasone diproprionate
4	M	63	174	77	2.8	89	Beclometasone diproprionate
5	F	67	155	68	1.55	84	None
6	M	23	170	79	4	96	None
7	F	39	161	63	3.5	126	Beclometasone diproprionate
8	M	38	189	92	3.8	84	None
9	M	41	182	96	3.8	92	Budesonide
10	M	41	176	87	3.8	98	None
11	M	52	172	88	3.05	90	None
12	F	62	166	105	1.95	81	Beclometasone diproprionate
13	M	66	173	78	2.4	80	Beclometasone diproprionate
14	M	48	166	79	2.75	84	Fluticasone
15	M	49	164	68	2.8	89	Budesonide
16	M	42	179	67	3.55	89	Beclometasone diproprionate
17	F	65	161	64	2	93	None
18	F	27	157	57	2.8	96	Fluticasone
19	F	34	161	71	2.9	100	Fluticasone
20	F	44	166	60	2.35	82	Fluticasone
Mean (SD)		48 (13)	167 (10)	77 (13)	2.9 (0.7)	91 (11)